Henry O Gosebruch Abb Vie Inc. (ABBV) insider trading activity

Henry O Gosebruch is EVP, Chief Strategy Officer of AbbVie Inc.. Currently has a direct ownership of 16,623 shares of ABBV, which is worth approximately $3.23 Million. The most recent transaction as insider was on May 16, 2022, when has been sold 83,960 shares (Common Stock, $0.01 par value) at a price of $155.0 per share, resulting in proceeds of $13,013,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.6K

0% 3M change

0% 12M change

Total Value Held $3.23 Million

Henry O Gosebruch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	SELL Open market or private sale	$13,013,800 $155.0 p/Share	83,960 Reduced 83.47%	16,623 Common Stock, $0.01 pa...
May 16 2022	BUY Exercise of conversion of derivative security	$4,606,046 $54.86 p/Share	83,960 Added 45.5%	100,583 Common Stock, $0.01 pa...
Mar 01 2022	SELL Open market or private sale	$3,703,250 $148.13 p/Share	25,000 Reduced 60.06%	16,623 Common Stock, $0.01 pa...
Mar 01 2022	SELL Open market or private sale	$2,226,450 $148.43 p/Share	15,000 Reduced 26.49%	41,623 Common Stock, $0.01 pa...
Feb 25 2022	SELL Payment of exercise price or tax liability	$4,509,528 $149.54 p/Share	30,156 Reduced 34.75%	56,623 Common Stock, $0.01 pa...
Feb 17 2022	BUY Grant, award, or other acquisition	-	68,068 Added 43.96%	86,779 Common Stock, $0.01 pa...
Sep 07 2021	SELL Bona fide gift	-	30,000 Reduced 61.59%	18,711 Common Stock, $0.01 pa...
Feb 28 2021	SELL Payment of exercise price or tax liability	$2,460,027 $107.74 p/Share	22,833 Reduced 31.91%	48,711 Common Stock, $0.01 pa...
Feb 18 2021	BUY Grant, award, or other acquisition	-	51,538 Added 41.87%	71,544 Common Stock, $0.01 pa...
Nov 20 2020	SELL Open market or private sale	$3,293,119 $99.49 p/Share	33,100 Reduced 62.33%	20,006 Common Stock, $0.01 pa...
Nov 20 2020	SELL Open market or private sale	$681,927 $98.83 p/Share	6,900 Reduced 11.5%	53,106 Common Stock, $0.01 pa...
Apr 06 2020	SELL Bona fide gift	-	18,500 Reduced 23.57%	60,006 Common Stock, $0.01 pa...
Feb 28 2020	SELL Payment of exercise price or tax liability	$2,224,166 $85.42 p/Share	26,038 Reduced 24.91%	78,506 Common Stock, $0.01 pa...
Feb 20 2020	BUY Grant, award, or other acquisition	-	58,781 Added 35.99%	104,544 Common Stock, $0.01 pa...
Aug 14 2019	SELL Bona fide gift	-	30,000 Reduced 39.6%	45,763 Common Stock, $0.01 pa...
Jul 29 2019	BUY Open market or private purchase	$2,018,400 $67.28 p/Share	30,000 Added 28.37%	75,763 Common Stock, $0.01 pa...
Feb 28 2019	SELL Payment of exercise price or tax liability	$1,822,936 $79.41 p/Share	22,956 Reduced 33.41%	45,763 Common Stock, $0.01 pa...
Feb 21 2019	BUY Grant, award, or other acquisition	-	51,815 Added 42.99%	68,719 Common Stock, $0.01 pa...
Dec 09 2018	SELL Payment of exercise price or tax liability	$1,169,264 $86.96 p/Share	13,446 Reduced 44.3%	16,904 Common Stock, $0.01 pa...
Nov 29 2018	SELL Open market or private sale	$3,824,745 $90.1 p/Share	42,450 Reduced 58.31%	30,350 Common Stock, $0.01 pa...
Feb 28 2018	SELL Payment of exercise price or tax liability	$2,059,853 $118.26 p/Share	17,418 Reduced 19.31%	72,800 Common Stock, $0.01 pa...
Feb 15 2018	BUY Grant, award, or other acquisition	-	39,316 Added 30.35%	90,218 Common Stock, $0.01 pa...
Dec 09 2017	SELL Payment of exercise price or tax liability	$1,365,848 $95.95 p/Share	14,235 Reduced 21.85%	50,902 Common Stock, $0.01 pa...
Oct 30 2017	SELL Open market or private sale	$1,661,274 $90.78 p/Share	18,300 Reduced 21.93%	65,137 Common Stock, $0.01 pa...
Jul 31 2017	SELL Open market or private sale	$1,262,520 $70.14 p/Share	18,000 Reduced 17.69%	83,737 Common Stock, $0.01 pa...

Also insider at

APTX

Aptinyx Inc. Healthcare

SLRN

ACELYRIN, Inc.

Director

NMRA

Neumora Therapeutics, Inc.

President & CEO

HOG